Cargando…
Thyroid Cancer and COVID-19: Prospects for Therapeutic Approaches and Drug Development
Thyroid cancer is the most prevalent endocrine malignancy and the reported incidence of thyroid cancer has continued to increase in recent years. Since 2019, coronavirus disease 2019 (COVID-19) has been spreading worldwide in a global pandemic. COVID-19 aggravates primary illnesses and affects disea...
Autores principales: | Qu, Na, Hui, Zongguang, Shen, Zhixin, Kan, Chengxia, Hou, Ningning, Sun, Xiaodong, Han, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9114699/ https://www.ncbi.nlm.nih.gov/pubmed/35600591 http://dx.doi.org/10.3389/fendo.2022.873027 |
Ejemplares similares
-
Mortality Risk of Antidiabetic Agents for Type 2 Diabetes With COVID-19: A Systematic Review and Meta-Analysis
por: Kan, Chengxia, et al.
Publicado: (2021) -
Calycosin induces autophagy and apoptosis via Sestrin2/AMPK/mTOR in human papillary thyroid cancer cells
por: Qu, Na, et al.
Publicado: (2022) -
BAM15 as a mitochondrial uncoupler: a promising therapeutic agent for diverse diseases
por: Xiong, Guoji, et al.
Publicado: (2023) -
Epigenetics Modifications and Therapeutic Prospects in Human Thyroid Cancer
por: Catalano, Maria Graziella, et al.
Publicado: (2012) -
Empagliflozin Attenuates Obesity-Related Kidney Dysfunction and NLRP3 Inflammasome Activity Through the HO-1–Adiponectin Axis
por: Ye, Tongtong, et al.
Publicado: (2022)